Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
BMC Public Health|January 15, 2024
Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022Håkon Bøås, Margrethe Larsdatter Storm, German Tapia, et al.
Clinical and Vaccine Immunology : CVI|June 26, 2015
International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEKaren L Laurie, Othmar G Engelhardt, John Wood, et al.
Emerging Infectious Diseases|April 1, 2009
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 seasonAdam Meijer, Angie Lackenby, Olav Hungnes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|October 21, 2016
Improving influenza virological surveillance in Europe: strain-based reporting of antigenic and genetic characterisation data, 11 European countries, influenza season 2013/14Eeva Broberg, Olav Hungnes, Brunhilde Schweiger, et al.
Infection Ecology & Epidemiology|January 4, 2018
Human to animal transmission of influenza A(H1N1)pdm09 in a turkey breeder flock in NorwaySiri Kulberg Sjurseth, Britt Gjerset, Karoline Bragstad, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 21, 2022
Risk factors, immune response and whole-genome sequencing of SARS-CoV-2 in a cruise ship outbreak in NorwayKirsten Gravningen, Stian Henriksen, Olav Hungnes, et al.
Microorganisms|December 24, 2021
Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021Brita Askeland Winje, Trine Skogset Ofitserova, Ola Brønstad Brynildsrud, et al.
Vaccines|November 26, 2024
Immune Response Against Influenza in a Cohort of Repeatedly Vaccinated Adults During the 2017/2018 and 2018/2019 SeasonsRaquel Guiomar, Susana Pereira da Silva, Ana Paula Rodrigues, et al.
Influenza and Other Respiratory Viruses|November 9, 2021
Trends in seroprevalence of SARS-CoV-2 and infection fatality rate in the Norwegian population through the first year of the COVID-19 pandemicGro Tunheim, Gunnar Øyvind Isaksson Rø, Trung Tran, et al.
Blood|November 8, 2011
Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatmentOlav Erich Yri, Dag Torfoss, Olav Hungnes, et al.
Pageof 9